Skip to main content
. 2022 Oct 10;114(11):1533–1544. doi: 10.1093/jnci/djac160

Table 4.

GWAS loci with CNVs associated with EOC or HGSOC risk (P < .05)

Cytoband rsID GWAS P LD block start LD block end
NMOC loci
 3q28 rs9869209 6.61E-09 190508818 192626025
 5p15.33 rs4449583 2.76E-21 982137 2132328
 10p12.31 rs7084454 1.86E-12 19427949 22483354
 17q21.31a rs146596949 1.26E-51 41743558 43694719
 17q21.31a rs575499584 4.12E-18 44979537 47798656
 17q21.32 rs12946636 9.92E-25 47798656 49440038
 19p13.11 rs4808075 5.76E-26 16263605 18299052
HGSOC associated loci
 4q13.2/4q13.3 rs4149419 2.66E-08 67989047 70183435
 5p15.33 rs4449583 1.09E-19 982137 2132328
 9q31.1 rs2122577 2.94E-09 103205694 104819468
 9p22.1/9p21.3 rs7851336 2.54E-10 18661053 20463536
 10p12.31 rs7084454 1.48E-09 19427949 22483354
 13q13.1 rs11571815 4.32E-09 31727678 33202766
 15q26.1 rs76119208 3.36E-09 89932319 91621162
 17q12 rs11657964 2.63E-12 36141651 38653091
 17q21.31 rs146596949 3.11E-56 41743558 43694719
 17q21.31 rs575499584 1.69E-19 44979537 47798656
 17q21.32 rs12946636 5.54E-19 47798656 49440038
 19p13.11 rs56069439 8.41E-38 16263605 18299052
a

BRCA1 locus. CNV = copy number variants; GWAS = genome-wide association analysis; LD = linkage disequilibrium; HGSOC = high-grade serous ovarian cancer; NMOC = all nonmucinous ovarian cancer.